Pfizer: the decline loses steam
Pfizer stock rebounds 1.9% as the sell signal shows signs of running out of steam
Pfizer: the decline loses steam
Our view last week
Pfizer dropped 2% this week, with 96% of trading volume on the sell side: buyers pulled back after last week's bounce. In our Pfizer technical analysis, the Sell signal has been under management for 11 weeks, and the short remains only marginally in profit. The stock still holds the double bottom in the 24 area, with money flow staying positive: a contested picture, with the trend losing conviction.
This week's summary
Pfizer's technical picture is softening: the MACD has improved for a fourth straight week and money flow has swung back to buying, while price action shows a bullish weekly structure with zero warning flags. The stock added 1.9% in a week that closed almost evenly split between buyers and sellers, though it remains boxed into a tight band between resistance and support in the 25 area. Pfizer stock is still carrying an active sell signal, but the downside push is clearly running out of steam.
IQS Phase
61
ordinary
Signal Strength
9
decline fading out
Sizing
MINIMUM
Ranking
#69 / 138
US stocks
Trade P&L %
+2.61%
from signal to date, no stop loss
Rank position
ranks 69th among the 138 sell signals for US stocks in our ranking, with a signal strength of 9 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly -0.01% · monthly +1.89%
PFE belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content